Procter & Gamble (PG) EBITDA (2009 - 2026)

Procter & Gamble (PG) has 18 years of EBITDA data on file, last reported at $4.6 billion in Q1 2026.

• On a quarterly basis, EBITDA changed 0.39% year-over-year to $4.6 billion in Q1 2026; TTM through Mar 2026 was $20.2 billion, a 0.86% increase from a year earlier, with the FY2025 full-year figure at $20.5 billion, up 10.28% from the prior year.
• EBITDA for Q1 2026 stood at $4.6 billion, down from $5.4 billion in the prior quarter.
• Over the last five years, EBITDA for PG reached as high as $5.9 billion in Q3 2025 and fell as low as $3.6 billion in Q2 2022.
• Historically, EBITDA has averaged $4.7 billion across 5 years, with a median of $4.6 billion in 2025.
• Across the five-year window, EBITDA declined 7.41% in 2022 and increased 29.51% in 2024, its largest moves.
• Year by year, EBITDA stood at $4.8 billion in 2022, then fell by 7.36% to $4.4 billion in 2023, then increased by 29.51% to $5.7 billion in 2024, then fell by 6.53% to $5.4 billion in 2025, then decreased by 14.72% to $4.6 billion in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $4.6 billion in Q1 2026, $5.4 billion in Q4 2025, and $5.9 billion in Q3 2025.